Galectin-3 modulates T cell activity and is reduced in the inflamed intestinal epithelium in IBD

Inflammatory Bowel Diseases

Volumn 12, Issue 7, 2006, Pages 588-597

  Müller, Stefan ^a   Schaffer, Thomas ^a   Flogerzi, Beatrice ^a   Fleetwood, Andrew ^a   Weimann, Rosemarie ^a   Schoepfer, Alain M ^a   Seibold, Frank ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Cell death; Galectin 3; IBD; Proliferation; T cells

Indexed keywords

GALECTIN 3; MESSENGER RNA; MITOGENIC AGENT; RECOMBINANT PROTEIN; RNA; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR;

ADULT; AGED; APOPTOSIS; ARTICLE; BASOLATERAL MEMBRANE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DOWN REGULATION; ENDOSCOPIC BIOPSY; ENTERITIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; IN VITRO STUDY; INTESTINE CELL; INTESTINE MUCOSA; MALE; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REMISSION; T LYMPHOCYTE ACTIVATION;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; EPITHELIUM; FEMALE; GALECTIN 3; HUMANS; INFLAMMATION; INFLAMMATORY BOWEL DISEASES; INTESTINES; KINETICS; MALE; MIDDLE AGED; REMISSION INDUCTION; T-LYMPHOCYTES;

EID: 33745576192     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/01.MIB.0000225341.37226.7c     Document Type: Article

References (35)

1. Hirabayashi J, Kasai K. The family of metazoan metal-independent beta-galactoside-binding lectins: structure, function and molecular evolution. Glycobiology. 1993;3:297-304.
2. Leffler H, Carlsson S, Hedlund M, Introduction to galectins. J. Glycoconj. 2004;19:433-440.
3. Rabinovich GA, Rubinstein N, Fainboim L. Unlocking the secrets of galectins: a challenge at the frontier of glyco-immunology. J Leukoc Biol. 2002;71:741-752.
4. Rubinstein N, Ilarregui JM, Toscano MA, et al. The role of galectins in the initiation, amplification and resolution of the inflammatory response. Tissue Antigens. 2004;64:1-12.
5. Krzeslak A, Lipinska A. Galectin-3 as a multifunctional protein. Cell Mol Biol Lett. 2004;9:305-328.
6. Ochieng J, Furtak V, Lukyanov P. Extracellular functions of galectin-3. J. Glycoconj. 2004;19:527-535.
7. Menon RP, Hughes RC. Determinants in the N-terminal domains of galectin-3 for secretion by a novel pathway circumventing the endoplasmic reticulum-Golgi complex. Eur J Biochem. 1999;264:569-576.
8. Sato S, Burdett I, Hughes RC. Secretion of the baby hamster kidney 30-kDa galactose-binding lectin from polarized and nonpolarized cells: a pathway independent of the endoplasmic reticulum-Golgi complex. Exp Cell Res. 1993;207:8-18.
9. Sato S, Hughes RC. Regulation of secretion and surface expression of Mac-2, a galactoside-binding protein of macrophages. J Biol Chem. 1994;269:4424-4430.
10. Akahani S, Nangia-Makker P, Inohara H, et al. Galectin-3: a novel antiapoptotic molecule with a functional BH1 (NWGR) domain of Bcl-2 family. Cancer Res. 1997;57:5272-5276.
11. Yang RY, Hsu DK, Liu FT. Expression of galectin-3 modulates T-cell growth and apoptosis. Proc Natl Acad Sci U S A. 1996;93:6737-6742.
12. Fukumori T, Takenaka Y, Yoshii T, et al. CD29 and CD7 mediate galectin-3-induced type II T-cell apoptosis. Cancer Res. 2003;63:8302-8311.
13. Stillman BN, Hsu DK, Pang M, et al. Galectin-3 and galectin-1 bind distinct cell surface glycoprotein receptors to induce T cell death. J Immunol. 2006;176:778-789.
14. Dagher SF, Wang JL, Patterson RJ. Identification of galectin-3 as a factor in pre-mRNA splicing. Proc Natl Acad Sci U S A. 1995;92:1213-1217.
15. Patterson RJ, Wang W, Wang JL. Understanding the biochemical activities of galectin-1 and galectin-3 in the nucleus. J Glycoconj. 2004;19:499-506.
16. Hughes RC. Secretion of the galectin family of mammalian carbohydrate-binding proteins. Biochim Biophys Acta. 1999;1473:172-185.
17. Nio J, Kon Y, Iwanaga T. Differential cellular expression of galectin family mRNAs in the epithelial cells of the mouse digestive tract. J Histochem Cytochem. 2005;53:1323-1334.
18. Almkvist J, Karlsson A. Galectins as inflammatory mediators. J Glycoconj. 2004;19:575-581.
19. Rabinovich GA, Baum LG, Tinari N, et al. Galectins and their ligands: amplifiers, silencers or tuners of the inflammatory response? Trends Immunol. 2002;23:313-320.
20. Sano H, Hsu DK, Yu L, et al. Human galectin-3 is a novel chemoattractant for monocytes and macrophages. J Immunol. 2000;165:2156-2164.
21. Sano H, Hsu DK, Apgar JR, et al. Critical role of galectin-3 in phagocytosis by macrophages. J Clin Invest. 2003;112:389-397.
22. Nieminen J, St-Pierre C, Sato S. Galectin-3 interacts with naive and primed neutrophils, inducing innate immune responses. J Leukoc Biol. 2005;78:1127-1135.
23. Joo HG, Goedegebuure PS, Sadanaga N, et al. Expression and function of galectin-3, a beta-galactoside-binding protein in activated T lymphocytes. J Leukoc Biol. 2001;69:555-564.
24. Jensen-Jarolim E, Gscheidlinger R, Oberhuber G, et al. The constitutive expression of galectin-3 is downregulated in the intestinal epithelia of Crohn's disease patients, and tumour necrosis factor alpha decreases the level of galectin-3-specific mRNA in HCT-8 cells. Eur J Gastroenterol Hepatol. 2002;14:145-152.
25. Best WR, Becktel JM, Singleton JW, et al. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology. 1976;70:439-444.
26. Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med. 1987;317:1625-1629.
27. Brunner T, Mogil RJ, LaFace D, et al. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature. 1995;373:441-444.
28. Dabelic S, Supraha S, Dumic J. Galectin-3 in macrophage-like cells exposed to immunomodulatory drugs. Biochim Biophys Acta. 2006;1760:701-709.
29. Ilarregui JM, Bianco GA, Toscano MA, et al. The coming of age of galectins as immunomodulatory agents: impact of these carbohydrate binding proteins in T cell physiology and chronic inflammatory disorders. Ann Rheum Dis. 2005;64:iv96-iv103.
30. Liu FT. Regulatory roles of galectins in the immune response. Int Arch Allergy Immunol. 2005;136:385-400.
31. Colnot C, Ripoche MA, Milon G, et al. Maintenance of granulocyte numbers during acute peritonitis is defective in galectin-3-null mutant mice. Immunology. 1998;94:290-296.
32. Hsu DK, Yang RY, Pan Z, et al. Targeted disruption of the galectin-3 gene results in attenuated peritoneal inflammatory responses. Am J Pathol. 2000;156:1073-1083.
33. Butz EA, Bevan MJ. Massive expansion of antigen-specific CD8+ T cells during an acute virus infection. Immunity. 1998;8:167-175.
34. Murali-Krishna K, Altman JD, Suresh M, et al. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity. 1998;8:177-187.
35. Tsuchiyama Y, Wada J, Zhang H, et al. Efficacy of galectins in the amelioration of nephrotoxic serum nephritis in Wistar Kyoto rats. Kidney Int. 2000;58:1941-1952.